Vignesh Rajah's Insider Trades & SAST Disclosures

Vignesh Rajah's most recent trade in Y-Mabs Therapeutics Inc was a trade of 1,711 Common Stock done at an average price of $16.5 . Disclosure was reported to the exchange on March 5, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER 05 Mar 2024 1,711 33,889 (0%) 0% 16.5 28,283 Common Stock
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER 18 Jan 2024 35,700 35,700 - - Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER 18 Jan 2024 17,800 35,600 (0%) 0% 0 Common Stock
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER 26 Jan 2023 32,000 32,000 - - Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER 17 Jan 2023 35,700 35,700 - - Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER 17 Jan 2023 17,800 17,800 (0%) 0% 0 Common Stock
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CMO 15 Nov 2022 1,195 4,266 (0%) 0% 4.9 5,884 Common Stock
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CMO 26 Apr 2022 20,000 20,000 - - Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CMO 14 Dec 2021 32,000 32,000 - - Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CMO 12 Aug 2021 1,374 3,071 (0%) 0% 29.9 41,147 Common Stock
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP & CMO 15 Dec 2020 20,000 20,000 - - Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP and CMO 17 Nov 2020 1,464 1,464 (0%) 0% 45.7 66,963 Common Stock
Y-Mabs Therapeutics Inc
Vignesh Rajah SVP and CMO 17 Nov 2020 233 1,697 (0%) 0% 51.0 11,890 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades